BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Arno Therapeutics 

30 Two Bridges Road
Suite 270
Fairfield  New Jersey  07004  U.S.A.
Phone: 862-703-7170 Fax: 973-227-5759


SEARCH JOBS










 Company News
Arno Therapeutics Doses First Patient In Expansion Stage Of Modified Phase 1/2 Trial Evaluating Onapristone In Progesterone Receptor Positive Tumors 12/10/2014 7:22:54 AM
Arno Therapeutics To Present Data Further Validating Diagnostic Development Of CDX For Onapristone At San Antonio Breast Cancer Symposium 2014 12/9/2014 1:06:42 PM
Arno Therapeutics Appoints Alexander Zukiwski, M.D. To Board Of Directors 12/5/2014 9:23:41 AM
Arno Therapeutics To Present At LD Micro Conference 2014 11/24/2014 1:47:31 PM
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014 10:49:00 AM
Arno Therapeutics' Executive Selected To Present At 5th Annual Clinical Affairs And Regulatory Approvals For Diagnostics Conference 10/29/2014 7:53:58 AM
Arno Therapeutics Advances Phase I Trial Evaluating Onapristone In Progesterone Receptor Positive Tumors To Expansion Stage 10/27/2014 7:40:46 AM
Arno Therapeutics To Present Encouraging Data From Ongoing Phase 1/2 Trial Evaluating Onapristone In CRPC At 21st Annual PCF Scientific Retreat 10/23/2014 7:24:30 AM
Arno Therapeutics To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014 7:38:13 AM
Arno Therapeutics' Executive Selected To Chair World CDx Boston 2014 9/18/2014 11:27:26 AM
1234567